<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>ChinaCSR.com &#187; Health</title>
	<atom:link href="http://www.chinacsr.com/en/category/health/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.chinacsr.com/en</link>
	<description>Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China</description>
	<lastBuildDate>Tue, 07 Feb 2012 06:17:22 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Legal Action Against Counterfeit Cigarettes In America Could Impact Chinese Makers</title>
		<link>http://www.chinacsr.com/en/2011/07/11/8314-legal-action-against-counterfeit-cigarettes-in-america-could-impact-chinese-makers/</link>
		<comments>http://www.chinacsr.com/en/2011/07/11/8314-legal-action-against-counterfeit-cigarettes-in-america-could-impact-chinese-makers/#comments</comments>
		<pubDate>Mon, 11 Jul 2011 00:18:08 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Law & Order]]></category>
		<category><![CDATA[cigarette]]></category>
		<category><![CDATA[counterfeit]]></category>
		<category><![CDATA[court]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[manufacturer]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[Philip Morris]]></category>
		<category><![CDATA[product quality]]></category>
		<category><![CDATA[trademark]]></category>
		<category><![CDATA[website]]></category>

		<guid isPermaLink="false">http://www.chinacsr.com/en/?p=8314</guid>
		<description><![CDATA[Cigarette-maker Philip Morris USA filed two lawsuits last week in U.S. District Court against 34 New York City retailers for selling counterfeit versions of the company's Marlboro brand cigarettes. Philip Morris says it continues to take action against counterfeit sellers to protect its trademarks, support law enforcement, promote the lawful sale of its brands and [...]]]></description>
		<wfw:commentRss>http://www.chinacsr.com/en/2011/07/11/8314-legal-action-against-counterfeit-cigarettes-in-america-could-impact-chinese-makers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Collaboration In China Aims To Provide Low-cost Medicines</title>
		<link>http://www.chinacsr.com/en/2011/06/09/8293-new-collaboration-in-china-aims-to-provide-low-cost-medicines/</link>
		<comments>http://www.chinacsr.com/en/2011/06/09/8293-new-collaboration-in-china-aims-to-provide-low-cost-medicines/#comments</comments>
		<pubDate>Thu, 09 Jun 2011 00:30:51 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Hisun]]></category>
		<category><![CDATA[hospital]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[pharamceutical]]></category>
		<category><![CDATA[Zhejiang]]></category>

		<guid isPermaLink="false">http://www.chinacsr.com/en/?p=8293</guid>
		<description><![CDATA[China's Zhejiang Hisun Pharmaceuticals announced the signing of a memorandum of understanding to form a joint venture with Pfizer Inc. to strengthen the ability of both companies to reach more patients with high-quality and low-cost medicines in the branded generics arena. Under the MOU, the two companies will explore a potential business collaboration focused on [...]]]></description>
		<wfw:commentRss>http://www.chinacsr.com/en/2011/06/09/8293-new-collaboration-in-china-aims-to-provide-low-cost-medicines/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Carrefour&#039;s Beijing Stores Gain Green Market Certification</title>
		<link>http://www.chinacsr.com/en/2011/05/16/8268-carrefours-beijing-stores-gain-green-market-certification/</link>
		<comments>http://www.chinacsr.com/en/2011/05/16/8268-carrefours-beijing-stores-gain-green-market-certification/#comments</comments>
		<pubDate>Mon, 16 May 2011 00:36:58 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Consumer]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Carrefour]]></category>
		<category><![CDATA[CCIC]]></category>
		<category><![CDATA[China Certification & Inspection Group]]></category>
		<category><![CDATA[Green]]></category>
		<category><![CDATA[Green Market Certification]]></category>
		<category><![CDATA[organic]]></category>
		<category><![CDATA[retail]]></category>
		<category><![CDATA[supermarket]]></category>

		<guid isPermaLink="false">http://www.chinacsr.com/en/?p=8268</guid>
		<description><![CDATA[China Certification &#038; Inspection Group has reportedly issued the Green Market Certification to Carrefour's six stores in Beijing, making the French supermarket one of the first retailers to gain the certification in the Beijing region. Liu Shengming, chairman of CCIC, told local media that the Green Market Certification has been fully launched in the retail [...]]]></description>
		<wfw:commentRss>http://www.chinacsr.com/en/2011/05/16/8268-carrefours-beijing-stores-gain-green-market-certification/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>American Medical Company Plans Physician Training With New Beijing Outpost</title>
		<link>http://www.chinacsr.com/en/2011/03/22/8237-american-medical-company-plans-physician-training-with-new-beijing-outpost/</link>
		<comments>http://www.chinacsr.com/en/2011/03/22/8237-american-medical-company-plans-physician-training-with-new-beijing-outpost/#comments</comments>
		<pubDate>Tue, 22 Mar 2011 12:41:43 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Education]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Africa]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[cardiology]]></category>
		<category><![CDATA[clinic]]></category>
		<category><![CDATA[Costa Rica]]></category>
		<category><![CDATA[doctor]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[hospital]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Malaysia]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[physician]]></category>
		<category><![CDATA[St. Jude Medical]]></category>
		<category><![CDATA[training]]></category>

		<guid isPermaLink="false">http://www.chinacsr.com/en/?p=8237</guid>
		<description><![CDATA[U.S.-based St. Jude Medical Inc. has opened a new facility in Beijing to provide physicians throughout China with practical experiences to improve the quality of therapy delivery and help enhance patient outcomes. The new Advanced Technology Center adds a key center for education and learning. When the facility is running at capacity, more than 2,000 [...]]]></description>
		<wfw:commentRss>http://www.chinacsr.com/en/2011/03/22/8237-american-medical-company-plans-physician-training-with-new-beijing-outpost/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Healthcare Chief Named For GE China</title>
		<link>http://www.chinacsr.com/en/2010/12/13/8165-new-healthcare-chief-named-for-ge-china/</link>
		<comments>http://www.chinacsr.com/en/2010/12/13/8165-new-healthcare-chief-named-for-ge-china/#comments</comments>
		<pubDate>Mon, 13 Dec 2010 07:23:29 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[GE]]></category>
		<category><![CDATA[General Electric]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[Rachel Duan]]></category>

		<guid isPermaLink="false">http://www.chinacsr.com/en/?p=8165</guid>
		<description><![CDATA[GE has named Rachel Duan as president and CEO of GE Healthcare China. In this new role,Duan will manage the development and implementation of integrated business strategy for the growth of GE Healthcare in China, which is a critical market for GE. Duan is an experienced global leader with over 15 years' experience in GE [...]]]></description>
		<wfw:commentRss>http://www.chinacsr.com/en/2010/12/13/8165-new-healthcare-chief-named-for-ge-china/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nutritional Products Firm Opens New Chinese Factory</title>
		<link>http://www.chinacsr.com/en/2010/11/15/8099-nutritional-products-firm-opens-new-chinese-factory/</link>
		<comments>http://www.chinacsr.com/en/2010/11/15/8099-nutritional-products-firm-opens-new-chinese-factory/#comments</comments>
		<pubDate>Sun, 14 Nov 2010 23:12:50 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Changsha]]></category>
		<category><![CDATA[direct sales]]></category>
		<category><![CDATA[farmer]]></category>
		<category><![CDATA[Herbalife]]></category>
		<category><![CDATA[Hunan]]></category>
		<category><![CDATA[manufacturing]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[retail]]></category>
		<category><![CDATA[rural]]></category>

		<guid isPermaLink="false">http://www.chinacsr.com/en/?p=8099</guid>
		<description><![CDATA[Herbalife Ltd. held a ground-breaking ceremony in Changsha, Hunan, for its state-of-the-art extraction facility for botanical extracts, powders and pure compounds to be used in its inner and outer nutrition products. Herbalife's 80,000 sq. ft. facility in Changsha will be capable of processing approximately 8,000 metric tons of raw materials annually through extraction, purification and [...]]]></description>
		<wfw:commentRss>http://www.chinacsr.com/en/2010/11/15/8099-nutritional-products-firm-opens-new-chinese-factory/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beijing Pharmacies Form Retail Business Health Alliance</title>
		<link>http://www.chinacsr.com/en/2010/11/12/8097-beijing-pharmacies-form-retail-business-health-alliance/</link>
		<comments>http://www.chinacsr.com/en/2010/11/12/8097-beijing-pharmacies-form-retail-business-health-alliance/#comments</comments>
		<pubDate>Thu, 11 Nov 2010 21:10:40 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Cachet]]></category>
		<category><![CDATA[drugstore]]></category>
		<category><![CDATA[Golden Elephant]]></category>
		<category><![CDATA[Haodekuai]]></category>
		<category><![CDATA[Jewim Pharmaceutical]]></category>
		<category><![CDATA[manufacturer]]></category>
		<category><![CDATA[manufacturing]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[pharmacy]]></category>
		<category><![CDATA[Yishou Baixing]]></category>

		<guid isPermaLink="false">http://www.chinacsr.com/en/?p=8097</guid>
		<description><![CDATA[Beijing's pharmacy chain operators, including Cachet, Golden Elephant, Yishou Baixing, Haodekuai, and Jewim Pharmaceutical have jointly initiated a pharmacy alliance, which is the seventh pharmacy alliance in the provincial-level market in China. The Beijing pharmacy alliance includes 23 drugstore chain retailers with over 800 stores, and their total annual sales are more than CNY3 billion. [...]]]></description>
		<wfw:commentRss>http://www.chinacsr.com/en/2010/11/12/8097-beijing-pharmacies-form-retail-business-health-alliance/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Abbot China Offers Exchange On Recalls In China</title>
		<link>http://www.chinacsr.com/en/2010/10/15/8029-abbot-china-offers-exchange-on-recalls-in-china/</link>
		<comments>http://www.chinacsr.com/en/2010/10/15/8029-abbot-china-offers-exchange-on-recalls-in-china/#comments</comments>
		<pubDate>Thu, 14 Oct 2010 19:30:42 +0000</pubDate>
		<dc:creator>editor</dc:creator>
				<category><![CDATA[Consumer]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Abbott]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[New Zealand]]></category>
		<category><![CDATA[recall]]></category>
		<category><![CDATA[Similac]]></category>
		<category><![CDATA[Singapore]]></category>
		<category><![CDATA[Taobao.com]]></category>
		<category><![CDATA[USA]]></category>

		<guid isPermaLink="false">http://www.chinacsr.com/en/?p=8029</guid>
		<description><![CDATA[Abbott Laboratories' China unit has said that the company is willing to exchange some recalled products purchased by Chinese consumers through unofficial distribution channelsother infant formula products being sold in China. Abbot earlier said that the Chinese market was unaffected by its recent recall of certain Similac-brand, powder infant formulas, as the products distributed in [...]]]></description>
		<wfw:commentRss>http://www.chinacsr.com/en/2010/10/15/8029-abbot-china-offers-exchange-on-recalls-in-china/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Abbott Says Chinese Market Not Affected By Recall Of Infant Formula</title>
		<link>http://www.chinacsr.com/en/2010/10/12/8021-abbott-says-chinese-market-not-affected-by-recall-of-infant-formula/</link>
		<comments>http://www.chinacsr.com/en/2010/10/12/8021-abbott-says-chinese-market-not-affected-by-recall-of-infant-formula/#comments</comments>
		<pubDate>Mon, 11 Oct 2010 19:30:39 +0000</pubDate>
		<dc:creator>editor</dc:creator>
				<category><![CDATA[Consumer]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Abbott]]></category>
		<category><![CDATA[beetle]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[infant formula]]></category>
		<category><![CDATA[New Zealand]]></category>
		<category><![CDATA[Similac]]></category>
		<category><![CDATA[Singapore]]></category>
		<category><![CDATA[USA]]></category>

		<guid isPermaLink="false">http://www.chinacsr.com/en/?p=8021</guid>
		<description><![CDATA[Abbott Laboratories, a pharmaceuticals health care company based in the U.S, has said that the Chinese market was not affected by its voluntary recall of its Similac-brand powder infant formula. The company said that no products distributed in China by Abbott Nutrition were affected by the recent proactive and voluntary recall of some products in [...]]]></description>
		<wfw:commentRss>http://www.chinacsr.com/en/2010/10/12/8021-abbott-says-chinese-market-not-affected-by-recall-of-infant-formula/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Two Zhangguang 101 Hair Products Banned In Hong Kong</title>
		<link>http://www.chinacsr.com/en/2010/08/05/7853-two-zhangguang-101-hair-products-banned-in-hong-kong/</link>
		<comments>http://www.chinacsr.com/en/2010/08/05/7853-two-zhangguang-101-hair-products-banned-in-hong-kong/#comments</comments>
		<pubDate>Wed, 04 Aug 2010 21:30:06 +0000</pubDate>
		<dc:creator>editor</dc:creator>
				<category><![CDATA[Consumer]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Beijing Zhangguang 101 Science and Technology Development Company]]></category>
		<category><![CDATA[department of health]]></category>
		<category><![CDATA[hair care]]></category>
		<category><![CDATA[hong kong]]></category>
		<category><![CDATA[Minoxidil]]></category>
		<category><![CDATA[shampoo]]></category>
		<category><![CDATA[Zhang Guang 101]]></category>

		<guid isPermaLink="false">http://www.chinacsr.com/en/?p=7853</guid>
		<description><![CDATA[The department of health of the Hong Kong Special Administrative Region government recently urged local residents not to buy or use two hair care products as they were found to contain an unapproved western medicine: Minoxidil. The two products, which are manufactured by mainland herbal shampoo maker Beijing Zhangguang 101 Science and Technology Development Company, [...]]]></description>
		<wfw:commentRss>http://www.chinacsr.com/en/2010/08/05/7853-two-zhangguang-101-hair-products-banned-in-hong-kong/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

